Vanguard Group Inc Neogenomics Inc Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Neogenomics Inc stock. As of the latest transaction made, Vanguard Group Inc holds 14,239,887 shares of NEO stock, worth $158 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,239,887

Previous 14,044,094 1.39%

Holding current value

$158 Million

Previous $207 Million 13.29%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	BUY	$13.0 - $18.43 $2.55 Million - $3.61 Million	195,793 Added 1.39%	14,239,887 $235 Million
Q3 2024 Nov 13, 2024	SELL	$13.4 - $17.73 $1.04 Million - $1.37 Million	-77,396 Reduced 0.55%	14,044,094 $207 Million
Q2 2024 Aug 13, 2024	SELL	$13.01 - $15.77 $1.16 Million - $1.41 Million	-89,529 Reduced 0.63%	14,121,490 $196 Million
Q1 2024 May 10, 2024	BUY	$14.06 - $16.79 $581,437 - $694,333	41,354 Added 0.29%	14,211,019 $223 Million
Q4 2023 Feb 14, 2024	SELL	$11.67 - $20.73 $1.71 Million - $3.04 Million	-146,536 Reduced 1.02%	14,169,665 $229 Million
Q3 2023 Nov 14, 2023	SELL	$12.15 - $17.85 $3.94 Million - $5.79 Million	-324,613 Reduced 2.22%	14,316,201 $176 Million
Q2 2023 Aug 14, 2023	BUY	$14.1 - $19.83 $10.9 Million - $15.3 Million	770,257 Added 5.55%	14,640,814 $235 Million
Q1 2023 May 15, 2023	BUY	$9.09 - $19.45 $1.78 Million - $3.81 Million	195,812 Added 1.43%	13,870,557 $241 Million
Q4 2022 Feb 10, 2023	BUY	$6.45 - $12.07 $3.23 Million - $6.04 Million	500,037 Added 3.8%	13,674,745 $126 Million
Q3 2022 Nov 14, 2022	SELL	$7.86 - $12.91 $1.11 Million - $1.83 Million	-141,693 Reduced 1.06%	13,174,708 $113 Million
Q2 2022 Aug 12, 2022	BUY	$7.06 - $13.97 $2.44 Million - $4.83 Million	345,898 Added 2.67%	13,316,401 $109 Million
Q1 2022 May 13, 2022	BUY	$12.15 - $35.28 $1.38 Million - $4.01 Million	113,534 Added 0.88%	12,970,503 $158 Million
Q4 2021 Feb 14, 2022	BUY	$30.49 - $48.49 $5.69 Million - $9.05 Million	186,607 Added 1.47%	12,856,969 $439 Million
Q3 2021 Nov 12, 2021	BUY	$41.66 - $52.52 $19.7 Million - $24.8 Million	472,802 Added 3.88%	12,670,362 $611 Million
Q2 2021 Aug 13, 2021	BUY	$36.62 - $51.69 $447 Million - $630 Million	12,197,560 New	12,197,560 $551 Million

Others Institutions Holding NEO

# of Institutions

282

Shares Held

124M

Call Options Held

751K

Put Options Held

107K

View Full List

About NEOGENOMICS INC

Ticker NEO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 125,796,000
Market Cap $1.4B
Description
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments. The company offers testing services to hospitals, reference labs, pathologists, oncologists, clinicians, pharmaceutical firms, and researchers. It provides cytoge...

More about NEO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Neogenomics Inc Transaction History